Evaluation of epidermal nerve density and opioid receptor levels in psoriatic itch

Keratinocyte-derived anosmin-1, an extracellular glycoprotein encoded by the X-linked Kallmann syndrome gene, is involved in modulation of epidermal nerve density in atopic dermatitis

(2010) Suhandy Tengara et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Opioid-induced pruritus: an update

(2009) A. Reich et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Opioids and the skin - where do we stand?

(2009) Paul L. Bigliardi et al.   EXPERIMENTAL DERMATOLOGY

Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis

(2009) Mitsutoshi Tominaga et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Histological Characterization of Cutaneous Nerve Fibers Containing Gastrin-Releasing Peptide in NC/Nga Mice: An Atopic Dermatitis Model

(2009) Mitsutoshi Tominaga et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inflammatory Cytokine Tumor Necrosis Factor-α Enhances Nerve Growth Factor Production in Human Keratinocytes, HaCaT Cells

(2009) Koji Takaoka et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Itch without pain—a labeled line for itch sensation?

(2009) Hermann O. Handwerker et al.   Nature Reviews Neurology

Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study

(2009) H. Kumagai et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Nalfurafine prevents 5′-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5′-guanidinonaltrindole-elicited scratching behavior in mice

(2009) S. Inan et al.   NEUROSCIENCE

Decreased production of semaphorin 3A in the lesional skin of atopic dermatitis

(2008) M. Tominaga et al.   BRITISH JOURNAL OF DERMATOLOGY

Effects of Atypical  -Opioid Receptor Agonists on Intrathecal Morphine-Induced Itch and Analgesia in Primates

(2008) M.-C. Ko et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS